ucsf banner
Home    :   Contact Us
Diane Havlir, MD

Diane V. Havlir, MD
Professor of Medicine, UCSF

Chief, HIV/AIDS Division at San Francisco General Hospital

Chair HIV/TB Working Group of the Stop TB Partnership

Research Interests
HIV therapeutic strategies

HIV and co-infections (Tuberculosis and Malaria)

Select Publications

1) Havlir, D.V., R. Bassett, D. Levitan, P. Gilbert, P. Tebas, A.C. Collier, M.S. Hirsch, C. Ignacio, J. Condra, H.F. Gunthard, D.D. Richman, and J.K. Wong, Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA, 2001. 286(2): p. 171-9.
2) Havlir, D.V., M.C. Strain, M. Clerici, C. Ignacio, D. Trabattoni, P. Ferrante, and J.K. Wong, Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J Virol, 2003. 77(20): p. 11212-9.
3) Havlir, D.V. and S.M. Hammer, Patents versus patients? Antiretroviral therapy in India. N Engl J Med, 2005. 353(8): p. 749-51.
4) Huang, L., A. Quartin, D. Jones, and D.V. Havlir, Intensive care of patients with HIV infection. N Engl J Med, 2006. 355(2): p. 173-81.
5) Kamya, M.R., A.F. Gasasira, A. Yeka, N. Bakyaita, S.L. Nsobya, D. Francis, P.J. Rosenthal, G. Dorsey, and D. Havlir, Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. J Infect Dis, 2006. 193(1): p. 9-15.

View PubMed results for Diane V. Havlir, MD

Education & Training

BA, St. Olaf College, Northfield, Minnesota, 1980

MD, Duke University Medical School, Durham, North Carolina, 1984

Categorical Internal Medicine Residency, University of California, San Francisco, 1984-1987

Fellowship, Infectious Diseases, Case Western Reserve University, Cleveland, Ohio, 1988-1990